Mangalam Drugs and Organics Ltd share price logo

Mangalam Drugs and Organics Ltd (MANGALAM)

₹107.882.47%

Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹105.73
    ₹109.49
  • 52 Week's Low

    52 Week's High

    ₹90.8
    ₹132.45
1 Month Return-0.76 %
3 Month Return+ 3.47 %
1 Year Return-2.2 %
Previous Close₹105.28
Open₹105.79
Volume32.09K
Upper Circuit-
Lower Circuit-
Market Cap₹166.64Cr

Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹166.64 Cr
P/B Ratio1.02
EPS0

Company Information

Mangalam Drugs and Organics Ltd is an India-based manufacturer of organic and inorganic chemicals, active pharma ingredients, API perfumery, disperse dye intermediates, bulk drugs, and bulk drug intermediates. Established in April 1972, the company has operations at Vapi in Gujarat and Sangamner in Maharashtra, and a Research and Development base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, dyes and intermediaries, Nimesulide, Amodiaquine Hydrochloride and Amodiaquine. The bulk drug production capacity of the Company was increased from 350 MTPA to 1260 MTPA between 2003-04 and 2009-10. In addition to this, the company developed and introduced two new bulk drugs: Bisoprolol Fumarate and Pantaprazole Sodium. Furthermore, an Intellectual Property Rights (IPR) and Regulatory Affairs Cell have been created for proper management and expansion of their products.

Share Price: ₹107.88 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹166.64Cr as of today
Revenue: ₹101.94Cr as on March 2024 (Q1 24)
Net Profit: ₹3.53Cr as on March 2024 (Q1 24)
Listing date: 23 May, 2005
Chairperson Name: Govardhan M Dhoot
OrganisationMangalam Drugs and Organics Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Mangalam Drugs and Organics Ltd

  • Mangalam Global Enterprise to Boost Production Capabilities - 25 Jun, 2024

    Mangalam Global Enterprise has acquired an Edible Oil Refinery & Packing Unit and an Oil Seed crushing plant, which is expected to enhance its production capabilities. The recent increase in MSP on various Kharif crops may also help boost the company's financials.

  • Mangalam Industrial Finance Reports Strong Q4 Results - 01 Jun, 2024

    Mangalam Industrial Finance reported a YoY revenue growth of 37.13% and reduced its loss by 98.25%. However, QoQ revenue declined by 43.12%, and the company experienced an increase in loss by 160.25%. The SG&A expenses rose by 32.72% QoQ, impacting profitability. The EPS for Q4 showed positive growth of 97.01% YoY. The stock delivered -3.06% return last week but strong returns of 37.62% in the last 6 months and 2.97% YTD.

Insights on Mangalam Drugs and Organics Ltd

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 49.42% to 49.47% in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 89.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.32% of holdings in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 171.8%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.26% to 0.21% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, MANGALAM stock has moved down by -44.2%

Company Financials

Value in ₹ crore
2023Y/Y Change
Total Assets
₹359.62Cr
↑9.26%
Total Liabilities
₹207.66Cr
↑16.28%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹39.52Cr
↑53.71%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
50.32%
0.00
Foreign Institutions
0.21%
-18.58
Mutual Funds
0%
0.00
Retail Investors
49.47%
0.10
Others
0%
0.00

Key Indicators

Earnings and Dividends

  • Mangalam Drugs and Organics Ltd Dividends December,2017

    In the quarter ending September 2017, Mangalam Drugs and Organics Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.47%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Mangalam Drugs and Organics Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Mangalam Drugs and Organics Ltd shares.

Mangalam Drugs and Organics Ltd (MANGALAM) share price today is ₹107.88

Mangalam Drugs and Organics Ltd is listed on NSE

Mangalam Drugs and Organics Ltd is listed on BSE

  • Today’s highest price of Mangalam Drugs and Organics Ltd is ₹109.49.
  • Today’s lowest price of Mangalam Drugs and Organics Ltd is ₹105.73.

Today’s traded volume of Mangalam Drugs and Organics Ltd(MANGALAM) is 32.09K.

Today’s market capitalisation of Mangalam Drugs and Organics Ltd(MANGALAM) is ₹166.64Cr.

Mangalam Drugs and Organics Ltd(MANGALAMPrice
52 Week High
₹132.45
52 Week Low
₹90.8

Mangalam Drugs and Organics Ltd(MANGALAM) share price is ₹107.88. It is down -18.55% from its 52 Week High price of ₹132.45

Mangalam Drugs and Organics Ltd(MANGALAM) share price is ₹107.88. It is up 18.81% from its 52 Week Low price of ₹90.8

Mangalam Drugs and Organics Ltd(MANGALAMReturns
1 Day Returns
2.6%
1 Month Returns
-0.76%
3 Month Returns
3.47%
1 Year Returns
-2.2%